Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
  1. 4 Exercise or conversion Director acquired 9,826 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 9,826 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 9,826 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 9,826 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 9,826 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy Director bought 4,523 shares at $4.67 ($21,122)
  11. 4 Open-market buy Director bought 1,839 shares at $4.75 ($8,735)
  12. 4 Open-market buy Director bought 3,250 shares at $5.30 ($17,225)
  13. 4 Planned sale President and CEO sold 964 shares at $5.56 ($5,360)
  14. 4 Planned sale Chief Research Officer sold 154 shares at $4.91 ($756)
  15. 4 Exercise or conversion Chief Financial Officer acquired 1,702 shares (option exercise)
  16. 4 Planned sale General Counsel and Secretary sold 272 shares at $4.91 ($1,336)
  17. 4 Planned sale General Counsel and Secretary sold 8,928 shares at $4.79 ($42,765)
  18. 4 Exercise or conversion Chief Financial Officer acquired 44,368 shares (option exercise)
  19. 4 Planned sale President and CEO sold 36,838 shares at $4.67 ($172,033)
  20. 4 Planned sale Chief Research Officer sold 10,287 shares at $4.79 ($49,275)

Page 3 of 14 · 269 filings